Anti-SARS Nucleocaspid [6H3]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 152645 |
| Applications | IF WB |
| Antigen/Gene or Protein Targets | SARS coronavirus nucleocapsid protein |
| Synonyms | Nucleoprotein, Protein N, SARS coronavirus N protein, SARS CoV |
| Reactivity | Virus |
| Relevance | Severe acute respiratory syndrome coronavirus (SARS-CoV) genome encodes for four major structural proteins, namely nucleocaspid (N), spike (S), membrane (M) and envelope (E). The viral RNA is packaged by the N protein into a helical nucleocapsid. Other molecular aspects of SARS-CoV N protein have also been reported, including self-dimerization, RNA-binding capabilities and its ability to activate signal transduction pathways. In addition, it was shown to induce apoptosis and actin reorganization in mammalian cells under stressed conditions. |
| Host | Mouse |
| Immunogen | GST-N (residues 121-422) |
| Positive Control | SARS-CoV infected Vero E6 cells |
| Subclass | Inconclusive |
| Subclass Notes | Both Isotype assays negative |
| Myeloma Used | Sp2/0-Ag14 |
| Research Area | Virology |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference